إعلان
إعلان
PLRX
Pliant Therapeutics, Inc. Common Stock
1.32
USDبرعاية
+0.01
+1.15%
٠٩ يناير, ١٥:٤٤ UTC -5
مغلق
بعد الإغلاق
1.32
0.00
-0.38%
تقارير أرباح PLRX
النسبة الإيجابية المفاجئة
PLRX تفوق 14 من 22 آخر التقديرات.
64%
التقرير التالي
بيانات التقرير القادم
٠٢ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.40
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-6.98%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-51.22%
Pliant Therapeutics, Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, PLRX reported earnings of -0.43 USD per share (EPS) for Q3 25, beating the estimate of -0.53 USD, resulting in a 19.51% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.58% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 المحللين forecast an EPS of -0.40 USD, with revenue projected to reach -- USD, implying an نقصان of -6.98% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Pliant Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Pliant Therapeutics, Inc. Common Stock reported EPS of -$0.43, beating estimates by 19.51%, and revenue of $0.00, 0% as expectations.
How did the market react to Pliant Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 4.58%, changed from $1.53 before the earnings release to $1.60 the day after.
When is Pliant Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٢ مارس ٢٠٢٦.
What are the forecasts for Pliant Therapeutics, Inc. Common Stock's next earnings report?
Based on 9
المحللين, Pliant Therapeutics, Inc. Common Stock is expected to report EPS of -$0.40 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان